Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia NCT00049569 L1 Childhood Ac...
L2 Childhood Ac...
Non-T, Non-B Ch...
Recurrent Child...
T-cell Childhoo...
cytarabine
methotrexate
vincristine sul...
prednisone
pegaspargase
doxorubicin hyd...
imatinib mesyla...
cyclophosphamid...
etoposide
filgrastim
leucovorin calc...
asparaginase
therapeutic hyd...
1 Year - 21 Years National Cancer Institute (NCI) View Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia NCT00381680 B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 Years Children's Oncology Group View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00002744 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
prednisone
therapeutic hyd...
thioguanine
vincristine sul...
low-LET cobalt-...
low-LET photon ...
1 Year - 9 Years Children's Oncology Group View Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia NCT00003729 Leukemia
cytarabine
fludarabine pho...
idarubicin
- 17 Years European Organisation for Research and Treatment of Cancer - EORTC View Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia NCT00002812 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
idarubicin
mercaptopurine
methotrexate
pegaspargase
prednisone
thioguanine
vincristine sul...
radiation thera...
1 Year - 21 Years Children's Oncology Group View Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945 Acute Undiffere...
B-cell Adult Ac...
B-cell Childhoo...
L1 Adult Acute ...
L1 Childhood Ac...
L2 Adult Acute ...
L2 Childhood Ac...
Philadelphia Ch...
Philadelphia Ch...
Philadelphia Ch...
T-cell Adult Ac...
T-cell Childhoo...
Untreated Adult...
Untreated Child...
allopurinol
cyclophosphamid...
daunorubicin hy...
vincristine sul...
dexamethasone
asparaginase
filgrastim
imatinib mesyla...
methotrexate
cytarabine
trimethoprim-su...
mercaptopurine
leucovorin calc...
alemtuzumab
acyclovir
laboratory biom...
pharmacological...
15 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia NCT00022126 Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 Year Children's Oncology Group View Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia NCT00381680 B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 Years Children's Oncology Group View Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission NCT00382109 B-cell Childhoo...
Childhood Acute...
Graft Versus Ho...
L1 Childhood Ac...
L2 Childhood Ac...
T-cell Childhoo...
thiotepa
cyclophosphamid...
tacrolimus
methotrexate
sirolimus
total body irra...
1 Year - 21 Years Children's Oncology Group View Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia NCT00019409 Leukemia
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
mercaptopurine
methotrexate
prednisone
therapeutic hyd...
vincristine sul...
radiation thera...
1 Year - 20 Years National Institutes of Health Clinical Center (CC) View Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma NCT00003728 Leukemia
Lymphoma
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
etoposide
leucovorin calc...
mercaptopurine
methotrexate
methylprednisol...
mitoxantrone hy...
prednisolone
therapeutic hyd...
thioguanine
vincristine sul...
vindesine
allogeneic bone...
peripheral bloo...
- 17 Years National Cancer Institute (NCI) View Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia NCT00003729 Leukemia
cytarabine
fludarabine pho...
idarubicin
- 17 Years European Organisation for Research and Treatment of Cancer - EORTC View Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome NCT00005593 Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center View Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia NCT00003783 Leukemia
filgrastim
asparaginase
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
etoposide
idarubicin
leucovorin calc...
mercaptopurine
methotrexate
prednisone
vincristine sul...
radiation thera...
- 17 Years Children's Oncology Group View Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia NCT00381680 B-cell Childhoo...
L1 Childhood Ac...
L2 Childhood Ac...
Intermediate Ri...
vincristine sul...
prednisone
doxorubicin hyd...
pegaspargase
cytarabine
methotrexate
dexamethasone
etoposide
cyclophosphamid...
leucovorin calc...
filgrastim
asparaginase
mercaptopurine
1 Year - 29 Years Children's Oncology Group View Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia NCT00005945 Leukemia
cyclophosphamid...
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
pegaspargase
thioguanine
vincristine sul...
radiation thera...
1 Year - 9 Years Children's Oncology Group View Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia NCT00049569 L1 Childhood Ac...
L2 Childhood Ac...
Non-T, Non-B Ch...
Recurrent Child...
T-cell Childhoo...
cytarabine
methotrexate
vincristine sul...
prednisone
pegaspargase
doxorubicin hyd...
imatinib mesyla...
cyclophosphamid...
etoposide
filgrastim
leucovorin calc...
asparaginase
therapeutic hyd...
1 Year - 21 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia NCT00022126 Leukemia
asparaginase
cyclophosphamid...
cyclosporine
cytarabine
daunorubicin hy...
dexamethasone
doxorubicin hyd...
mercaptopurine
methotrexate
methylprednisol...
pegaspargase
thioguanine
vincristine sul...
allogeneic bone...
radiation thera...
- 1 Year Children's Oncology Group View Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome NCT00005593 Leukemia
Myelodysplastic...
carboplatin
fludarabine pho...
topotecan hydro...
12 Years - Case Comprehensive Cancer Center View